120 related articles for article (PubMed ID: 29218029)
1. Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy.
Penaforte-Saboia JG; Montenegro RM; Couri CE; Batista LA; Montenegro APDR; Fernandes VO; Akhtar H; Negrato CA; Malmegrim KCR; Moraes DA; Dias JBE; Simões BP; Gomes MB; Oliveira MC
Front Endocrinol (Lausanne); 2017; 8():331. PubMed ID: 29218029
[TBL] [Abstract][Full Text] [Related]
2. Lower Insulin-Dose Adjusted A1c (IDAA1c) Is Associated With Less Complications in Individuals With Type 1 Diabetes Treated With Hematopoetic Stem-Cell Transplantation and Conventional Therapy.
Penaforte-Saboia JG; Couri CEB; Fernandes VO; Montenegro APDR; Batista LAA; Zajdenverg L; Negrato CA; Malmegrim KCR; Moraes DA; Dias JBE; Oliveira MC; Hussain A; Gomes MB; Montenegro RM
Front Endocrinol (Lausanne); 2019; 10():747. PubMed ID: 31803138
[No Abstract] [Full Text] [Related]
3. Autologous hematopoietic stem cell transplantation and conventional insulin therapy in the treatment of children with newly diagnosed type 1 diabetes: long term follow-up.
Gu Y; Gong C; Peng X; Wei L; Su C; Qin M; Wang X; Li F
Chin Med J (Engl); 2014; 127(14):2618-22. PubMed ID: 25043077
[TBL] [Abstract][Full Text] [Related]
4. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Coutinho M; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK
JAMA; 2007 Apr; 297(14):1568-76. PubMed ID: 17426276
[TBL] [Abstract][Full Text] [Related]
5. Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.
Zhang X; Ye L; Hu J; Tang W; Liu R; Yang M; Hong J; Wang W; Ning G; Gu W
PLoS One; 2012; 7(2):e31887. PubMed ID: 22384093
[TBL] [Abstract][Full Text] [Related]
6. Emerging Aspects of the Body Composition, Bone Marrow Adipose Tissue and Skeletal Phenotypes in Type 1 Diabetes Mellitus.
Carvalho AL; Massaro B; Silva LTPE; Salmon CEG; Fukada SY; Nogueira-Barbosa MH; Elias J; Freitas MCF; Couri CEB; Oliveira MC; Simões BP; Rosen CJ; de Paula FJA
J Clin Densitom; 2019; 22(3):420-428. PubMed ID: 30100221
[TBL] [Abstract][Full Text] [Related]
7. Human Hematopoietic Stem/Progenitor Cells in Type One Diabetes Mellitus Treatment: Is There an Ideal Candidate?
Carulli E; Pompilio G; Vinci MC
Cells; 2023 Mar; 12(7):. PubMed ID: 37048127
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of microvascular complications in newly diagnosed patients with type 2 diabetes.
Ali A; Iqbal F; Taj A; Iqbal Z; Amin MJ; Iqbal QZ
Pak J Med Sci; 2013 Jul; 29(4):899-902. PubMed ID: 24353655
[TBL] [Abstract][Full Text] [Related]
9. Residual β-cell function in Brazilian Type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy.
Gabbay MAL; Crispim F; Dib SA
Diabetol Metab Syndr; 2023 Mar; 15(1):51. PubMed ID: 36935525
[TBL] [Abstract][Full Text] [Related]
10. Metabolic memory: Evolving concepts.
Misra A; Bloomgarden Z
J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
[TBL] [Abstract][Full Text] [Related]
11. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
[TBL] [Abstract][Full Text] [Related]
12. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
14. Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.
Xiang H; Yang C; Xiang T; Wang Z; Ge X; Li F; Su Y; Chen H; Huang X; Zeng Q
Stem Cells Transl Med; 2016 May; 5(5):651-7. PubMed ID: 27025691
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study.
Odawara M; Kadowaki T; Naito Y
J Diabetes Complications; 2015; 29(1):127-33. PubMed ID: 25449981
[TBL] [Abstract][Full Text] [Related]
16. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.
Gu B; Miao H; Zhang J; Hu J; Zhou W; Gu W; Wang W; Ning G
Diabetes Metab; 2018 Sep; 44(4):341-345. PubMed ID: 29331269
[TBL] [Abstract][Full Text] [Related]
18. Lack of persistent remission following initial recovery in patients with type 1 diabetes treated with autologous peripheral blood stem cell transplantation.
Walicka M; Milczarczyk A; Snarski E; Jedynasty K; Halaburda K; Torosian T; Urbanowska E; Król M; Jędrzejczak WW; Franek E
Diabetes Res Clin Pract; 2018 Sep; 143():357-363. PubMed ID: 30036612
[TBL] [Abstract][Full Text] [Related]
19. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT
Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610
[TBL] [Abstract][Full Text] [Related]
20. Correlation of serum CA199 levels with glycemic control and microvascular complications in patients with type 2 diabetes mellitus.
Tong W; Gao H; Wei X; Mao D; Zhang L; Chen Q; Zhang Z; Li Y
Am J Transl Res; 2021; 13(4):3302-3308. PubMed ID: 34017502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
